title: Prevalence and causes of low bone density and fractures in kidney transplant patients.
abstract: Osteoporosis is known to occur in patients with kidney transplants, but limited information is available about the prevalence and causes of this complication. We asked all 330 patients with kidney transplants in our unit to participate in this study of whom 165 (50%) agreed to do so. The characteristics of the participating patients were similar to the remaining 165 nonparticipants. Seventy of 165 (42%) of the participants were women of whom 40 were postmenopausal in contrast to the men of whom only one was hypogonadal. Bone mineral density (BMD) was significantly reduced at the radius (Z score, -1.5) and femoral neck (Z score, -0.7), but the lumbar spine was normal. BMD was lower in women than men at all skeletal sites. Osteoporosis was found in 10-44% and osteopenia was found in 35-50% of women depending on the site. BMD was related inversely to time since transplantation and cumulative prednisolone dose. Twenty-seven of the 165 (16%) patients had either vertebral deformities or a history of a low trauma fracture after transplantation. This fracture group consisted of 10/27 (37%) men and 17/27 (63%) women, of whom 14 were postmenopausal. Fracture patients tended to be older and have a longer duration of renal failure, dialysis, transplantation, greater cumulative steroid dose, and higher bone resorption markers than the nonfracture group. No differences were found for cumulative doses of cyclosporin or tacrolimus. Logistic regression showed that only duration of dialysis and time since transplantation significantly increased fracture risk, with odds ratio (OR) for each year of dialysis or transplantation being 1.21 (CI, 1.00-1.48) and 1.14 (CI, 1.05-1.23), respectively. These data show that low bone density and fractures are common in patients with kidney transplant and are determined by both pre- and posttransplant variables. Fracture risk was greatest in women, particularly if they were postmenopausal and we recommend that this subgroup is targeted for assessment and treatment.
authors.affiliation: Department of Rheumatology, St. Helier Hospital, Epsom and St. Helier NHS Trust, Carshalton, Surrey, United Kingdom.
authors.forename: S
authors.initials: S
authors.lastname: Patel
authors.forename: J T
authors.initials: JT
authors.lastname: Kwan
authors.forename: E
authors.initials: E
authors.lastname: McCloskey
authors.forename: G
authors.initials: G
authors.lastname: McGee
authors.forename: G
authors.initials: G
authors.lastname: Thomas
authors.forename: D
authors.initials: D
authors.lastname: Johnson
authors.forename: R
authors.initials: R
authors.lastname: Wills
authors.forename: L
authors.initials: L
authors.lastname: Ogunremi
authors.forename: J
authors.initials: J
authors.lastname: Barron
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001379:Azathioprine / Q000008:administration & dosage; D001416:Back Pain; D015415:Biomarkers / Q000097:blood / Q000652:urine; D015519:Bone Density; D016572:Cyclosporine / Q000008:administration & dosage; D005260:Female; D050723:Fractures, Bone / Q000097:blood / Q000453:epidemiology* / Q000503:physiopathology / Q000652:urine; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D015995:Prevalence; D016559:Tacrolimus / Q000008:administration & dosage; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D015415:Biomarkers; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D016559:Tacrolimus